Name | Erlotinib |
Synonyms | Tarceva ERLOTININ Erlotinib ERLOTINIB ERLOTINIB HCL Erlotinib Base ERLOTINIB HCL SALT Erlotinib Hydrochloirde 4-[(3-ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline 4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)- n-(3-ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine |
CAS | 183321-74-6 |
EINECS | 689-196-2 |
InChI | InChI=1/C22H23N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25) |
Molecular Formula | C22H23N3O4 |
Molar Mass | 393.44 |
Density | 1.24 |
Melting Point | 159-160 °C |
Boling Point | 553.6±50.0 °C(Predicted) |
Solubility | DMSO |
Appearance | White to off-white powder |
Color | White |
pKa | 5.32±0.30(Predicted) |
Storage Condition | Keep in dark place,Sealed in dry,Store in freezer, under -20°C |
Use | A tyrosine kinase inhibitor |
Safety Description | 24/25 - Avoid contact with skin and eyes. |
HS Code | 29335990 |